Search for: [Abstract = "Introductio nUse of contrast media in heart failure \(HF\) patients can cause a contrast\-induced nephropathy \(CIN\), which can be prevented by a continuous veno\-venous hemofiltration \(CVVH\). Aims To assess safety of CVVH, its influence on heart\- and renal failure markers, risk of CIN and prognosis. Methods Half of 52 HF and renal failure patients undergoing coronary angiography\/PCI were treated by CVVH \(group A\), while others were treated in a standard manner. Results In group A creatinine level decreased significantly at day 1 post PCI \(161,87±63,4 vs 124,71±39,8 μmol\/l, p=0,003\), while it raised in group B \(129,9±38,1 vs 136,4±43,6, p=0,049\). In group A, NT\-proBNP level dropped significantly but CRP level raised. CIN frequency in group A was non\-significantly lower \(15,4%, vs 26,9%, p=0,49\). Female gender was an independent predictor of CIN \(OR 2,15, CI \(1,03\-4,49\), p=0,04\). Puncture site bleedingincidence was higher in CVVH women. One\-year survival was significantly higher in group A \(p=0,03\). Conclusions CVVH in HF patients decreases creatinine and NT\-proBNP levels and non\-significantly lowers CIN risk, probably providing 1\-year survival benefit while increasing bleeding risk in women."]
